Document Detail


Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension.
MedLine Citation:
PMID:  22500728     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Eur J Clin Invest 2012 ABSTRACT: Background  Osteopontin (OPN) was found upregulated in several heart failure models and appears to play an important role in myocardial remodelling. As we have previously demonstrated that OPN predicts mortality in patients with pulmonary hypertension (PH), we now evaluated whether OPN also predicts adverse right ventricular (RV) remodelling and dysfunction in PH. Methods  We prospectively included 71 patients with PH of different etiology in this study. OPN plasma level were determined by ELISA and assessed for correlation with RV dilatation and dysfunction determined by echocardiography. Results  OPN plasma values significantly correlated with RV end-diastolic diameter, Tricuspid Annular Plane Systolic Excursion (TAPSE) and Tricuspid Annular Systolic Velocity (TASV) (r = 0·43, P = 0·0002; r = -0·46, P = 0·0006; r = -0·31, P = 0·02). Furthermore, stratification of our study population according to RV end-diastolic diameter and RV dysfunction revealed that patients with enlarged and functionally impaired RV's display higher OPN levels (956 ng/mL vs. 628 ng/mL, P = 0·0005; 1108 ng/mL vs. 792 ng/mL; P = 0·02). Next, we determined OPN cut-off values for the detection of RV remodelling and dysfunction by receiver operating curve analyses and further stratified these parameters in a multivariate analysis. Here, OPN emerged as an independent predictor of RV dilatation and dysfunction. Finally, we demonstrate synergism of OPN and NT-proBNP in the prediction of RV dilatation and dysfunction by calculation of the Rothman Synergy Index. Conclusion  In summary, OPN predicts adverse RV remodelling and dysfunction in PH. Together with our previously published data regarding OPN's value for the prognostication of death in PH, we believe that OPN can improve risk stratification in patients with PH beyond current assessment standards.
Authors:
Mark Rosenberg; F Joachim Meyer; Ekkehard Gruenig; Matthias Lutz; Dirk Lossnitzer; Rita Wipplinger; Hugo A Katus; Norbert Frey
Related Documents :
6216028 - Acute coronary artery occlusion during percutaneous transluminal coronary angioplasty: ...
2964948 - Clinical outcome 5 years after attempted percutaneous transluminal coronary angioplasty...
1990788 - Immediate and short-term results of a 1988-1989 coronary angioplasty registry.
10498128 - Comparison of protective effects of preinfarction angina pectoris in acute myocardial i...
25020898 - P518biomechanical properties, microstructure and constitutive modeling of human ventric...
17627108 - Out-of-hospital cardiac arrests in patients with acute st elevation myocardial infarcti...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-10
Journal Detail:
Title:  European journal of clinical investigation     Volume:  -     ISSN:  1365-2362     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-4-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0245331     Medline TA:  Eur J Clin Invest     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors. European Journal of Clinical Investigation © 2012 Stichting European Society for Clinical Investigation Journal Foundation.
Affiliation:
Department of Internal Medicine III, University Medical Center Schleswig-Holstein, Campus Kiel, Germany Department of Pneumology and Gastroenterology, Klinikum Harlaching, Munich, Germany Center of Pulmonary Hypertension, Thoraxklinik Heidelberg, Germany Department of Internal Medicine III, University of Heidelberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hyperbranched Glycopolymers for Blood Biocompatibility.
Next Document:  Sex differences in transcriptional expression of FABPs in zebrafish liver after chronic perfluoronon...